Hangming Dong

Title: Innovations by Hangming Dong in Cancer Treatment

Introduction

Hangming Dong is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of two patents, Dong focuses on developing compositions and methods that target specific cancer types.

Latest Patents

Dong's latest patents include compositions and methods for treating HIF-1α over-expressing cancers. These patents describe compositions that consist of monoclonal antibodies specifically designed to bind Hsp90α. The methods outlined in these patents aim to treat cancers such as breast cancer and lung cancer. The monoclonal antibodies target specific epitopes, including TKPIWTRNP and VKHFSVEGQ, in Hsp90α, providing a novel approach to cancer therapy.

Career Highlights

Dong is affiliated with the University of Southern California, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from HIF-1α over-expressing cancers.

Collaborations

Dong collaborates with esteemed colleagues, including Wei Li and David Woodley, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative solutions in the medical field.

Conclusion

Hangming Dong's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in the fight against cancer.